ClearVue Technologies Limited (CVUEF) Fair Value & Analysis
Technology · US · Market cap $31.6M
ClearVue Technologies Limited
CVUEF · US
Fair value as of: Jun 24, 2026
From 2 valuation models · updated 28 days ago
Share price −41.6% over the past month.
Price vs Fair Value (12 months)
12‑month range $0.0492 – $0.1915 · fair‑value band $0.0425 – $0.0680 · the $0.0600 price screens above the $0.0595 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
ClearVue Technologies Limited (CVUEF) currently trades at $0.0600, while our model-based Fair Value estimate is $0.0595, implying the stock looks roughly 0.8% fairly valued today. We read business quality at 22/100 (below-average quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at $358K. It earns a return on equity of -95.7%. Fundamentals as of Jun 24, 2026
Our scenario range runs from $0.0425 (bear case) to $0.0680 (bull case); at $0.0600, the current price sits within that range. The share trades about 69% below its 52-week high, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at 4% fair-value upside, at -1%, CVUEF screens richer than that median.
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
ClearVue Technologies Limited, together with its subsidiaries, provides building-integrated photovoltaic (BIPV) solutions in Australia. It offers solar façade, vision glass, spandrel, balustrade and skylight, and cladding and architectural BIPV, as well as greenhouse solar solutions. The company was formerly known as Tropiglas Technologies Limited and changed its name to ClearVue Technologies Limited in June 2015. ClearVue Technologies Limited was incorporated in 1995 and is headquartered in West Perth, Australia.
Revenue & earnings trend
FY2017 – FY2024 · reported fiscal years
ClearVue Technologies Limited reported revenue of $39.8K in FY2024 versus $60.8K in FY2017, a compound −5.9%/yr. Reported net income was −$12.5M in FY2024.
Is CVUEF fairly valued? → Check now
Similar stocks
10 more Solar stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| First Solar, Inc F3A | €261.50 | €271.11 | +4% |
| Nextpower Inc NXT | $131.57 | $79.08 | -40% |
| Tongwei Co 600438 | ¥13.70 | ¥29.90 | +118% |
| Waaree Energies Limited WAAREEENER | ₹3,053 | ₹4,337 | +42% |
| Jinko Solar Co 688223 | ¥5.15 | ¥7.41 | +44% |
| Hengdian Group 002056 | ¥29.24 | ¥22.76 | -22% |
| CSI Solar Co 688472 | ¥11.17 | ¥5.85 | -48% |
| Enphase Energy, Inc ENPH | $52.41 | $22.20 | -58% |
| Premier Energies Limited PREMIERENE | ₹1,080 | ₹670.05 | -38% |
| Trina Solar Co 688599 | ¥14.41 | ¥38.80 | +169% |
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is ClearVue Technologies Limited (CVUEF) undervalued?
What is the fair value of CVUEF?
What is the quality score of CVUEF?
What is the revenue of ClearVue Technologies Limited (CVUEF)?
What is the net profit margin of CVUEF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full ClearVue Technologies Limited analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.